Discussion This retrospective observational study, focusing on the use of ALC as add-on treatment in patients with FMS, revealed a long-term and statistically significant reduction in VAS scores and improvements in QoL as measured by FIQ-R
Scarlata G, Colaci C, Scarcella M, Dallio M, Federico A, Boccuto L, et al
Theyve helped with all kinds of immune conditions, in part by reducing inflammation, and we know that is an issue in long COVID. Desperate for therapies that work, the long COVID community has already begun experimenting with microdosing GLP-1 drugs, with a post made one year ago on the social news site Reddit entitled Ozempic for Long Covid? reporting anecdotal evidence of the drug helping some improve their symptoms
The SP@M recovers the balance of synovial microenvironment, and finally achieves bone remodeling and cartilage restoration in collagen-induced arthritis (CIA) mouse models (Fig
Wilberforce, T., Abdelkareem, M